Brief about the Glucagon-Like Peptide-1 (Glp-1) Analogs

Incretin mimetics, sometimes referred to as glucagon-like peptide-1 (GLP-1) analogs, are a family of medications used to treat type-2 diabetes mellitus and reduce blood sugar levels. GLP-1 analogues work by preventing the breakdown of GLP-1, which increases the release of glucose-dependent insulin, inhibits the release of glucagon (which lowers hepatic glucose output), and slows down gastric emptying rate (resulting in weight loss from reduced appetite). GLP-1 analogues, unlike other classes of anti-diabetic drugs, do not result in hypoglycemia. GLP-1.

Read More:

https://cmitoc.blogspot.com/2023/03/glucagon-like-peptide-1-glp-1-analogs.html